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Abstract
Background: The X-linked SRPX2 gene encodes a Sushi Repeat-containing Protein of unknown function and is mutated
in two disorders of the Rolandic/Sylvian speech areas. Since it is linked to defects in the functioning and the development
of brain areas for speech production, SRPX2 may thus have participated in the adaptive organization of such brain regions.
To address this issue, we have examined the recent molecular evolution of the SRPX2 gene.
Results: The complete coding region was sequenced in 24 human X chromosomes from worldwide populations and in
six representative nonhuman primate species. One single, fixed amino acid change (R75K) has been specifically
incorporated in human SRPX2 since the human-chimpanzee split. The R75K substitution occurred in the first sushi
domain of SRPX2, only three amino acid residues away from a previously reported disease-causing mutation (Y72S).
Three-dimensional structural modeling of the first sushi domain revealed that Y72 and K75 are both situated in the
hypervariable loop that is usually implicated in protein-protein interactions. The side-chain of residue 75 is exposed, and
is located within an unusual and SRPX-specific protruding extension to the hypervariable loop. The analysis of non-
synonymous/synonymous substitution rate (Ka/Ks) ratio in primates was performed in order to test for positive selection
during recent evolution. Using the branch models, the Ka/Ks ratio for the human branch was significantly different (p =
0.027) from that of the other branches. In contrast, the branch-site tests did not reach significance. Genetic analysis was
also performed by sequencing 9,908 kilobases (kb) of intronic SRPX2 sequences. Despite low nucleotide diversity, neither
the HKA (Hudson-Kreitman-Aguadé) test nor the Tajima's D test reached significance.
Conclusion: The R75K human-specific variation occurred in an important functional loop of the first sushi domain of
SRPX2, indicating that this evolutionary mutation may have functional importance; however, positive selection for R75K
could not be demonstrated. Nevertheless, our data contribute to the first understanding of molecular evolution of the
human SPRX2 gene. Further experiments are now required in order to evaluate the possible consequences of R75K on
SRPX2 interactions and functioning.
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Background
Evolution studies have been undertaken to identify those
genetic changes that underlie human-specific features
such as susceptibility to acquired immunodeficiency syn-
drome, bipedalism, a large brain, and higher-order cogni-
tive functions. Several phenotypic differences
distinguishing human from other great apes species obvi-
ously rely on cerebral activity. Large-scale studies in
human and chimpanzee using either genome compari-
sons [1,2] or brain transcriptome analyses [3-5] have led
to the identification of a subset of genes that may have
contributed to the evolution of human brain anatomy
and activity from a common primate ancestor. An impor-
tant complementary approach has relied on the study of
candidate genes selected on the basis of their importance
in specific human phenotypes. Consequently, several
genes involved in the structure and/or functioning of the
human brain have been associated with recent positive
selection:  ASPM  [6,7],  MCPH1  [8-10],  GLUD2  [11],
MAOA [12,13], SHH [14], and the "speech gene" FOXP2
[15-17]. More recently, accelerated evolution of noncod-
ing sequences has also been shown [18,19].
The Rolandic and Sylvian fissures divide the cortex hemi-
spheres of primates into their main anatomical structures.
In human, these areas participate in speech production
under the control of the Broca's area. We recently identi-
fied the SRPX2 gene as being responsible for two related
disorders of the Rolandic and Sylvian speech areas
[20,21]. Since it is linked to defects in the functioning and
the development of such brain regions, such as epileptic
seizures, oral and speech dyspraxia, or bilateral perisyl-
vian polymicrogyria, SRPX2 may be one of the specific
genes whose evolution at the DNA-level may have partic-
ipated in the recent emergence of higher-order cognitive
functions, including the adaptive organization of brain
areas for speech production.
In this study, we have examined the molecular evolution
of the SRPX2 gene. One single, fixed amino acid change
occurred in the first sushi domain (also known as CCP –
complement control protein – module, or short consen-
sus repeat) of SRPX2 after the human-chimpanzee split.
Three-dimensional modeling showed that both this evo-
lutionary mutation and a previously identified disease-
associated mutation [20] lie within a hypervariable loop
shared by all sushi modules and that has been implicated
in some cases in protein-protein interactions [22]. Using
the branch models, the synonymous/non-synonymous
analysis was consistent with accelerated evolution in the
human lineage but this could not be confirmed when the
branch-site models were used. Population genetics tests
did not reach statistical significance, indicating either that
a selective sweep may have occurred more than 100 000–
200 000 years ago, or that there has been no episode of
positive selection on SRPX2.
Results and discussion
One single amino acid substitution (R75K) has been fixed 
in human SRPX2 since the human-chimpanzee split
In silico screening of publicly available databases followed
by phylogenetic analysis showed that SRPX2 belongs to a
family of five genes: SRPX2 itself (sushi-repeat-containing
protein, X-linked 2), SRPX (sushi-repeat-containing pro-
tein, X-linked), SELP (selectin P precursor), SELE (selectin
E precursor), and SVEP1 (selectin-like protein) gene (Fig.
1; Additional file 1). This family emerged during verte-
brate evolution. In order to trace the recent evolutionary
history of SRPX2, all coding exons were sequenced from a
subset of primate species that represent key evolutionary
steps: human [Genbank: NM_014467], chimpanzee
[Genbank: EF369515], gorilla [Genbank: EF369516],
orangutan [Genbank: EF369517], gibbon [Genbank:
EF369518], macaque [Genbank: EF369519], and baboon
[Genbank: EF369520]. Sequence comparison (Fig. 2)
Phylogenetic tree of the SRPX2 family members Figure 1
Phylogenetic tree of the SRPX2 family members. ag: Anophe-
les gambiae; bt: Bos taurus; cn: Canis familiaris; dr: Danio 
rerio; gg: Gallus gallus; hs: Homo sapiens; mm: Mus musculus; 
ma: Macaca mulatta; rn: Rattus norvegicus; pt: Pan troglo-
dytes; tn: Takifugu rubripes; tr: Tetraodon nigroviridis. The 
list of the ENSEMBL gene accession numbers used to con-
struct the phylogenetic tree is available in Additional file 1.BMC Genetics 2007, 8:72 http://www.biomedcentral.com/1471-2156/8/72
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detected only five amino acid variant sites (1.1%; 5/465).
One discrepancy between the protein [Genbank:
ABN46998] predicted from the five chimpanzee SRPX2
sequences obtained here (see Methods section), and the
chimpanzee SRPX2 protein [Genbank: XP_521170] pre-
dicted from the genomic sequence at the UCSC database
[23], was detected (D429 in ABN46998; N429 in
XP_521170). This likely corresponds to an error in the
chimpanzee genome sequence previously available,
although it may be due to chimpanzee polymorphism.
The only amino acid substitution specific to the human
lineage is an Arg to Lys change at position 75, correspond-
ing to a 224A>G mutation within exon 4 of SRPX2. The
possible importance of the R75K substitution in the evo-
lution of the human species was indicated by the conser-
vation of R75 in all SRPX2 orthologues, from nonhuman
primates to ray-finned fishes, as well as by the fixation of
K75 in human, as demonstrated by the lack of any varia-
tion at position 75 in silico, in the 24 worldwide X-chro-
mosomes tested here, and in the 624 Caucasian control X-
chromosomes previously screened [20].
K75 is situated in the hypervariable loop that is usually 
implicated in protein-protein interactions
The R75K human-specific modification occurred in the
first sushi domain of the protein. Sushi domains have
been identified in several proteins of the complement sys-
tem and in the selectin family of proteins [24]. They may
serve in protein-protein interactions [22], as demon-
strated in the case of the neurocan-L1 interaction [25].
R75K occurs only three amino acid residues away from
the tyrosine residue (Y72) that is mutated in a patient with
rolandic seizures and bilateral perisylvian polymicrogyria
and in his female relatives with mild mental retardation
[20]. The amino acid residue at position 75 may thus par-
ticipate in the proper function of the first sushi domain of
SRPX2.
To further address this issue, three-dimensional modeling
of the first sushi module of the human SRPX2 protein (i.e.
sushi 1) was undertaken by homology with a known sushi
domain (CCP module) structure (Fig. 3; Additional file
2). Sushi domains are characterised by a compact hydro-
phobic core, containing an almost invariant Trp residue,
which is enclosed in a framework of five extended seg-
Three-dimensional modeling of the first sushi domain of  human SRPX2 Figure 3
Three-dimensional modeling of the first sushi domain of 
human SRPX2. A cartoon representation [65] is shown, high-
lighting the conserved Trp and Cys residues. The model 
reveals an additional putative disulfide bridge (Cys71-Cys87), 
atypical of the classical sushi (CCP) module fold. The hyper-
variable loop, with the sites of disease-causing mutation 
(Tyr72) and evolutionary change (Lys75) and the protrusion 
specific to SRPX, are indicated.
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Amino acid sequence alignment of SRPX2 from human and  nonhuman primates Figure 2
Amino acid sequence alignment of SRPX2 from human and 
nonhuman primates. Dots represent residues identical to the 
human amino acid sequence. Black lines represent the three 
Sushi domains and the dotted line represents the HYR 
domain. The site of the human-specific variation (R75K) is 
boxed.
g
Human     MASQLTQRGALFLLFFLTPAVTPTWYAGSGYYPDESYNEVYAEEVPQAPALDYRVPRWCY  60 
Chimp     ............................................................  60 
Gorilla   ...........S................................................  60 
Orangutan ..........FS................................................  60 
Gibbon    ...........S................................................  60 
Macaque   ...........S..................................R.............  60 
Baboon    ...........S..................................R.............  60 
Human     TLNIQDGEATCYSPKGGNYHSSLGTRCELSCDRGFRLIGRRSVQCLPSRRWSGTAYCRQM 120 
Chimp     ..............R............................................. 120 
Gorilla   ..............R............................................. 120 
Orangutan ..............R............................................. 120 
Gibbon    ..............R............................................. 120 
Macaque   ..............R............................................. 120 
Baboon    ..............R............................................. 120 
Human     RCHALPFITSGTYTCTNGVLLDSRCDYSCSSGYHLEGDRSRICMEDGRWSGGEPVCVDID 180 
Chimp     ............................................................ 180 
Gorilla   ............................................................ 180 
Orangutan ............................................................ 180 
Gibbon    ............................................................ 180 
Macaque   ............................................................ 180 
Baboon    ............................................................ 180 
Human     PPKIRCPHSREKMAEPEKLTARVYWDPPLVKDSADGTITRVTLRGPEPGSHFPEGEHVIR 240 
Chimp     ............................................................ 240 
Gorilla   ............................................................ 240 
Orangutan ............................................................ 240 
Gibbon    ............................................................ 240 
Macaque   ............................................................ 240 
Baboon    ............................................................ 240 
Human     YTAYDRAYNRASCKFIVKVQVRRCPTLKPPQHGYLTCTSAGDNYGATCEYHCDGGYDRQG 300 
Chimp     ............................................................ 300 
Gorilla   ............................................................ 300 
Orangutan ............................................................ 300 
Gibbon    ............................................................ 300 
Macaque   ............................................................ 300 
Baboon    ............................................................ 300 
Human     TPSRVCQSSRQWSGSPPICAPMKINVNVNSAAGLLDQFYEKQRLLIISAPDPSNRYYKMQ 360 
Chimp     ............................................................ 360 
Gorilla   ............................................................ 360 
Orangutan ............................................................ 360 
Gibbon    ...................T........................................ 360 
Macaque   ...................T........................................ 360 
Baboon    ...................T........................................ 360 
Human     ISMLQQSTCGLDLRHVTIIELVGQPPQEVGRIREQQLSANIIEELRQFQRLTRSYFNMVL 420 
Chimp     ............................................................ 420 
Gorilla   ............................................................ 420 
Orangutan ............................................................ 420 
Gibbon    ............................................................ 420 
Macaque   ............................................................ 420 
Baboon    ............................................................ 420 
Human     IDKQGIDRDRYMEPVTPEEIFTFIDDYLLSNQELTQRREQRDICE                465 
Chimp     .............................................                465 
Gorilla   .............................................                465 
Orangutan .............................................                465 
Gibbon    .............................................                465 
Macaque   .............................................                465 
Baboon    .............................................                465 BMC Genetics 2007, 8:72 http://www.biomedcentral.com/1471-2156/8/72
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ments that form β-strands for all or part of their lengths.
The extended segments are aligned with the long axis of
the module and are held together by two strictly con-
served disulfide bridges [24]. In a previously performed
cluster assignment exercise undertaken for more than 240
sushi domain sequences [26], the first sushi domain of
SRPX (which is highly similar to sushi 1) fell into cluster-
D, which also includes many modules found within the
selectin family of proteins.
In almost all sushi domains, a region that is highly varia-
ble in length, sequence and conformation, and com-
monly referred to as the hypervariable loop [27], is
inserted within the second extended region. Depending
on its length this projects laterally from the module and
forms an obvious candidate surface for protein-protein
recognition. Indeed, the hypervariable loop has been
implicated as a "hot-spot" for several protein-protein
interactions and disease-causing mutations in CCP-con-
taining complement proteins [22,28-30]. In the sushi 1
model (Fig. 3) an additional disulfide bridge (cysteine res-
idues C71-C87), atypical of the classical sushi domain
fold, is evident. Cys71 lies at the beginning of the hyper-
variable loop that is exceptionally long in sushi 1. The
hypervariable loop is thus forced to form a prominent
protrusion extending towards the N-terminus of the mod-
ule. This feature has neither been seen in any experimen-
tally determined sushi module structure to date, nor is
predicted to occur in other members of the D-cluster
except SRPX.
The Y72S mutation is largely solvent exposed and located
within the hypervariable loop, adjacent to the cysteine res-
idue (C71) that participates in the non-typical, third,
disulfide bridge. This change from a large aromatic side-
chain (tyrosine; Y) to a small, polar one (serine; S) at posi-
tion 72 will have a profound effect on the surface proper-
ties of this region that is close to the aforementioned
prominent protrusion. K75 is located nearby, within the
protrusion, and its side-chain is exposed (Fig. 3). It is rea-
sonable to suggest that the unique structure formed by the
hypervariable loop of sushi 1 performs a role that is spe-
cific to the SRPX2 protein. Presumably, it is not a coinci-
dence, that it is also the site of the human-specific change.
An R75K substitution is a conservative one; the substitu-
tion of one exposed, positively charged residue for
another can easily be accommodated by small atom shifts
in surrounding side-chains, and is not likely to affect the
structure of the sushi domain. Such a change might have
a small but not a dramatic functional effect. Conservative
substitutions are thought to play a role in adaptive change
[31]. Moreover, conservative R-to-K and K-to-R substitu-
tions can result in the altered properties of either secreted
proteins [32] or the extracellular domains of some plasma
membrane proteins [33,34], including a member of the
selectin family [35].
Analysis of non-synonymous/synonymous substitution rate 
ratio in primates
Human-specific modifications with putative functional
consequences may sustain positive selection since the
human-chimpanzee split. The ratio of non-synonymous
(Ka) to synonymous (Ks) substitution rates was then cal-
culated for each branch on the primate phylogenetic tree
(Fig. 4). Using the branch models, the Ka/Ks value in the
human lineage differed from all other branches with sta-
tistical significance (p = 0.027) (Additional file 3). In this
model, the calculated Ka/Ks ratio has an infinite value, as
no synonymous change has accumulated between the
human and the chimpanzee. However, this elevated Ka/
Ks ratio was not statistically >1 (p = 0.371) (Additional
file 3). Using the branch-site tests, model A indicated that
the K75 site might be under positive selection in the
human lineage. However, model A did not differ from the
null hypothesis with statistical significance (p = 0.089)
(Additional figure 3). Overall, positive selection in the
human lineage could not be clearly demonstrated, as the
branch-site analysis did not confirm the data obtained
using the branch models. This may be due either to the
actual absence of any positive selection, or to the lack of
power of the tests due to the low number of genetic varia-
tions within SRPX2.
Population genetics analysis
Evidence for positive selection can also be found by ana-
lyzing the intra-specific variation in DNA sequences sub-
jected to a selective sweep. DNA sequences adjacent to an
advantageous allele should display lower-than-expected
levels of diversity. The levels of polymorphism and diver-
Numbers of non-synonymous (left) and synonymous (right)  substitutions of different evolutionary lineages in primates Figure 4
Numbers of non-synonymous (left) and synonymous (right) 
substitutions of different evolutionary lineages in primates.
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gence were estimated by sequencing a total of 9,908 kb of
intronic sequences surrounding exon 4 of SRPX2 in the 24
X-chromosomes mentioned above. Polymorphic sites are
shown in Table 1. Nucleotide diversity at the SRPX2 locus
(π = 0.00036) was 76% of the estimated nucleotide diver-
sity on chromosome X (π = 0.00047) [36]. The divergence
between humans and chimpanzee for SRPX2  (D  =
0.0075) was nearly identical to the average divergence cal-
culated for X-linked intronic regions (D = 0.0072) [37].
The McDonald-Kreitman test [38] that measures the frac-
tion of site under positive selection pressure by comparing
the ratio of nonsynonymous to synonymous divergence
and the ratio of nonsynonymous to synonymous poly-
morphism, was useless in the case of SRPX2 because of the
very few number of inter- and intra-species DNA varia-
tions: no synonymous mutation and only one non-syn-
onymous mutation has occurred since the human-
chimpanzee split, and neither non-synonymous nor syn-
onymous polymorphisms were detected when 24 human
SRPX2  entire coding sequences from two sub-Saharan
African, three Asian, three Maghrebian, and four Cauca-
sian women were tested. Moreover, no polymorphism
had been detected in the 198 unrelated patients previ-
ously screened for disease-causing mutations in the cod-
ing sequence of SRPX2 [20]. It is also noteworthy that
while no synonymous polymorphism was found in silico,
one non-synonymous variation was detected in silico
[dbSNP:rs17851822]. Although the existence of a rare
DNA variation cannot be ruled out, this change was
detected in one single IMAGE clone only [Genbank:
BC020733; IMAGE:4769946]. This is more likely to corre-
spond to a clone artifact, as we indeed detected a large
proportion of clones carrying artifactual mutations within
SRPX2  inserts, using various Escherichia coli strains
(unpublished data).
The HKA (Hudson-Kreitman-Aguadé) test [39] was then
used in order to compare the intra- and inter-specific var-
iations between the SRPX2 locus and control loci assumed
to be under neutral selection, but did not yield significant
results (Table 2). The Tajima's D test was also applied to
the SRPX2 intron data. Tajima's D was clearly negative (D
= -0.646) but did not reach significance (p > 0.05). As in
Table 1: Polymorphic sites of SRPX2 introns 3 and 4 in 12 women worldwide.
Site* Intron 3 Intron 4
3478 3749 4292 4756 5115 6076 6783 7862 8433 9691 9700 10308 10446 10732 11286 2112 2202 2369
SNPs (ID) a b c d e f g h i j k l m n o p q r
Caucasian
1
T/T C/C C/C C/C C/C C/C G/G A/A G/G A/A T/T T/T T/T C/C G/G T/T C/C A/A
Caucasian
2
T/T C/C C/C C/T C/C C/C G/G A/A G/G A/A T/T T/A T/T C/C G/G T/T C/C A/A
Caucasian 
3
T/T C/C C/C C/C C/C C/C G/G A/C G/G A/G T/C T/T T/T C/T G/G T/T C/C A/A
Caucasian 
4
T/T C/C C/C C/C C/C C/C G/G A/A G/G A/A T/T T/T T/T C/C G/G T/T C/C A/A
Maghrebia 
1
T/T C/C C/C C/C C/C C/C G/G A/A G/G A/A T/T T/T T/T C/C G/G T/T C/C A/A
Maghrebia 
2
T/G C/C C/C C/C C/C C/C G/G A/C G/G A/G T/C T/T T/T C/C G/G T/T C/C A/A
Maghrebia 
3
T/T C/C C/C C/C C/C C/C G/G A/A G/G A/A T/T T/T T/T C/C G/G T/T C/C A/A
Asian
1
T/T C/C C/C C/C C/C C/C G/G A/C G/A A/G T/C T/T T/T C/T G/G C/C C/C A/A
Asian 
2
T/T C/C C/C C/C C/C C/C G/G A/A G/G A/A T/T T/T T/T C/C G/G T/T C/C A/A
Asian 
3
T/T C/C C/C C/C C/C C/C G/G A/C G/A A/G T/C T/T T/T C/T G/G T/C C/C A/A
African 
1
G/G C/C C/C C/C C/C C/T G/G C/C G/G G/G C/C T/T T/T C/T T/G T/T C/T A/G
African 
2
G/G T/T G/G C/C T/T C/C A/A C/C G/G G/G C/C T/T C/C T/T G/G T/T C/C G/G
* Numbers refer to the positions in the sequences of human introns 3 and 4, respectively. ** For those single nucleotide polymorphisms (SNPs) that 
were not reported in current databases [23,66] at the time of analysis and that appeared in one single individual only, PCRs were redone and both 
strands resequenced in order to exclude PCR artifacts. SNPs IDs at NCBI [66] are: a: rs6616171. b: ss52048551. c: ss52048547. d: ss52085994. e: 
ss52048549. f: ss52084549. g: ss52084548. h: rs5966711. i: ss52048552. j: ss52048553. k: ss52048554. l: ss52048546. m: rs5921619. n: rs5920840. o: 
ss52084547. p: rs5921620. q: ss52048548. r: rs2022475.BMC Genetics 2007, 8:72 http://www.biomedcentral.com/1471-2156/8/72
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the case of the ASPM gene that is involved in human brain
expansion [6], the present intra-specific analyses did not
show significant evidence against neutral expectations.
The lack of statistical significance may indicate that no
selective sweep has ever occurred in the human lineage.
However, it should be mentioned that a selective sweep
can be detected by intra-specific studies only for a short
period (< 0.5 N  generations, where N  is the effective
human population size, i.e. approximately < 100 000–
200 000 years ago) after fixation of the advantageous var-
iant [40,41].
Conclusion
In this study, we have examined the molecular evolution
of the SRPX2  gene that causes brain disorders of the
speech areas. One single, fixed amino acid change (R75K)
occurred in the first sushi domain of SRPX2 after the
human-chimpanzee split. Neither the primate analysis
nor the population genetics separately demonstrated the
existence of positive selection of SRPX2. Whether the sin-
gle human-specific R75K mutation has sustained positive
selection thus remains an open question. However the 3-
D location of R75K right within an important functional
domain of the SRPX2 protein, in the immediate vicinity of
a pathogenic mutation, indicates that this evolutionary
mutation may have functional importance. Because R75K
occurred in a domain implicated in protein-protein inter-
actions, it is possible that qualitative or quantitative
changes in the interaction with one or several putative
SRPX2 partners have been modified. Despite the present
lack of any knowledge on either the actual function of
SRPX2 or the proteins it interacts with, it is obvious that
the comparison of the properties of the human and chim-
panzee SRPX2 orthologues will help determine in the
future if and how new functions were acquired. From this
viewpoint, our study represents a first important step
towards the analysis of the consequences of R75K on
SRPX2 functioning and protein interactions.
Methods
DNA samples and sequencing
All human and nonhuman primate DNAs were extracted
using standard procedures and according to the appropri-
ate ethical committees and animal' care rules, respectively.
Polymerase chain reaction (PCR) fragments representing
9,908 kb from introns 3 and 4 were sequenced with spe-
cific primers in 12 human females from the major conti-
nental populations (two sub-Saharan Africans, four
Europeans, three Asians, and three Maghrebians). Each
exon of the full-length coding region of SRPX2 was ampli-
fied by PCR and sequenced in the same 12 women and in
six nonhuman primate species, using inter-specific con-
sensus intronic primers. The nonhuman primates were of
the hominidae, pongidae, hylobatidae, and cercopitheci-
dae families: three chimpanzees (one male and two
females; Pan troglodytes); one gorilla (Gorilla gorilla); one
orangutan (Pongo pygmaeus), one gibbon (Hylobates sp.),
one macaque (Macaca mulatta) and one baboon (Papio
sp.). The primer sequences are listed in Additional file 4.
Sequencing was performed using standard dye terminator
chemistry. Sequences were analysed and polymorphisms
detected using the Genalys 3.0 software [42]. Multiple
sequence alignments were performed using the ClustalW
program [43].
Modeling analyses
Modeling of the first sushi module of human SRPX2 was
undertaken based upon its closest homologue in the Pro-
tein Data Bank (PDB) [44,45]: the highest resolved X-ray
structure of the first sushi module of complement receptor
type 2 (PDB ID: 1LY2) [46], which was identified with a
BLAST search [47,48]. The target and template shared
29% sequence identity from N- to C-terminal cysteines.
The program Modeller release 8 version 1 [49] was used.
The alignment between the target and template sequences
was based on an initial multiple sequence alignment of
several individual human sushi-module sequences
assigned to cluster-D (with the addition of template
sequence CR2 module 1), using the program ProbCons
Table 2: Nucleotide polymorphism and divergence at SRPX2
Sequence length (nt) π (%) θ (%) Divergence D (%) θ/D HKA probability
β-globin initiation at 11p15 [67] 6076 0.129 0.107 1.284 0.083 0.696
Noncoding region at 22q11 [68] 9901 0.088 0.139 1.353 0.103 0.605
Dystrophin intron-dys44 at Xp21 [69] 7475 0.135 0.102 0.604 0.169 0.499
PDHA1 introns at Xp22 [70] 3530 0.225 0.211 0.992 0.213 0.168
Noncoding region at Xq13.3 [71] 10200 0.045 0.083 0.922 0.090 0.655
SRPX2 introns at Xq22 (this study) 9908 0.048 (0.036) 0.062 (0.047) 0.750 0.084
nt: nucleotide; π: nucleotide diversity per site; for X chromosome data, π is corrected by multiplication by 4/3 and the uncorrected value is in 
brackets. θ: Watterson's estimate of polymorphism per site; for X chromosome data, θ is corrected by multiplication by 4/3 and the uncorrected 
value is in brackets. D: number of nucleotide differences per site between human and chimpanzee sequences. HKA probability: probability from the 
HKA test, with comparison to the SRPX2 intron data.BMC Genetics 2007, 8:72 http://www.biomedcentral.com/1471-2156/8/72
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[50] to help position indels more appropriately (see Addi-
tional file 2 for target-template alignment). Cluster-D
members, according to the recently published convention
of sequence assignment [26], are characterized by the
presence of a six-cysteine residue motif, forming three
putative disulfide bridges. The target-template sequence
alignment was subjected to further, minor manual editing
guided by positioning of secondary structure elements
more appropriately between the target and template
sequences; secondary structure was predicted by the server
PsiPred version 2.4 [51,52] for the target sequence, or
identified by DSSP [53] for the template structure. The
additional putative disulfide bridge present in the target
(absent in its corresponding template) was restrained dur-
ing model building. Twenty-five models were generated,
and the one with the lowest objective function score [49]
selected as the representative model. The loop KGGNY in
the hypervariable loop region of SRPX2, for which CR2-
template-derived restraints were largely absent was subse-
quently remodeled under SYBYL version 6.9 (Tripos Asso-
ciates, St. Louis, MO, USA) after we conducted a loop
search for that region against a high resolution subset of
the PDB, in order to select the best root-mean square fit-
ting matching loop conformation for that region.
Non-identical side-chain residues of the representative
model were optimized using the side-chain replacement
program SCWRL version 3 [54]. The model was then pro-
tonated and subjected to energy minimization using the
Tripos forcefield [55] (20 steps steepest descent followed
by 20 steps conjugate gradient) under SYBYL to remove
clashes and bad geometries. The model structure was
finally checked for valid stereochemistry using PRO-
CHECK version 3.5.4 [56].
Evolution data analyses
The phylogenetic analysis was performed using the phyl-
ogenomic analysis pipeline available in the FIGENIX [57]
automated genomic annotation platform [58] with the
human SRPX2 protein sequence [Genbank: NP_055282]
as input and the NCBI nr or the Ensembl databases for
BLAST searches (Additional file 1). The synonymous/non
synonymous analyses were conducted in primates assum-
ing the following unrooted tree topology: (Baboon,
Macaque, ((((Chimpanzee, Human), Gorilla), Orangu-
tan), Gibbon)). Ancestral sequences were reconstructed
with the pamp and codeml programs in the PAML pack-
age [59,60], using the parsimony method and the maxi-
mum likelihood method, respectively. From these data,
the number of synonymous and non-synonymous substi-
tutions and the Ka/Ks ratios were estimated using the
DnaSP 4.0 package [61]. The codeml program from the
PAML 3.15 packages was used to test for positive selec-
tion, using the branch models and the branch-site mod-
els, as previously described [62,63] (Additional file 3).
The DnaSP 4.0 program was also used for all population
genetic analyses. Nucleotide diversity (π) and Watterson's
θ were computed as described [64]. The neutral evolution
hypothesis for the SRPX2 intronic polymorphisms was
checked with the HKA (Hudson-Kreitman-Aguadé) test
[39], using available data on worldwide polymorphisms
in non-coding reference (neutral) autosomal and X-linked
regions of the human genome (Table 2), as previously
described [16].
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